Monsanto grants access to transformation method
Academic institutions and other not-for-profit organisations will be given a royalty-free research licence to a newly issued US patent awarded to Monsanto this month. The patent (US 8,273,954) covers an Agrobacterium tumefaciens-mediated transformation method for dicotyledonous plants. It was first filed in 1983. Royalty-free access to “one of the leading agricultural biotechnologies” will further the enablement and development of key agriculture solutions for farmers and consumers alike, says Robb Fraley, chief technology officer for Monsanto and a co-inventor named in the patent. Interested parties can access a downloadable request form for the research licence on Monsanto's website at www.monsanto.com. Monsanto's A tumefaciens transformation technology has been previously licensed to other major technology developers for commercial purposes. Commercial licences will continue to be available.